Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 15Prostatic Neoplasms 12Neoplasms 11Brain Neoplasms 10Lung Neoplasms 9Glioma 9Glioblastoma 9Carcinoma, Non-Small-Cell Lung 6Pancreatic Neoplasms 5Ovarian Neoplasms 5Colorectal Neoplasms 5Rectal Neoplasms 4Carcinoma, Hepatocellular 4Uterine Cervical Neoplasms 3Multiple Myeloma 3Esophageal Neoplasms 3Colonic Neoplasms 3Anus Neoplasms 3Urinary Bladder Neoplasms 2Thyroid Cancer, Papillary 2Small Cell Lung Carcinoma 2Recurrence 2Oligodendroglioma 2Neurotoxicity Syndromes 2Neuroendocrine Tumors 2Melanoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Leukemia, Myeloid, Acute 2

Interventions

Echocardiography 11Electrocardiography 5Trastuzumab 4Social Determinants of Health 2Doxorubicin 2Chemoradiotherapy 2Blood Specimen Collection 2Antineoplastic Agents 2Vascular Stiffness 1Standard of Care 1Resistance Training 1Pulse Wave Analysis 1Positron Emission Tomography Computed Tomography 1Magnetic Resonance Spectroscopy 1Immunomodulating Agents 1Hematologic Tests 1Gonadal Steroid Hormones 1Exercise Test 1EGFR tyrosine kinase inhibitor 324674 1Clinical Laboratory Techniques 1Cisplatin 1Cardiography, Impedance 1Anthracyclines 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Cardiotoxicity × Magnetic Resonance Spectroscopy × Clear all
NCT00875238 2018-02-19

PACE in BC

Vanderbilt University Medical Center

Completed
133 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡